<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>p57KIP2 is a potent tight-binding inhibitor of several G1 cyclin/Cdk complexes, and is a negative regulator of cell proliferation </plain></SENT>
<SENT sid="1" pm="."><plain>The gene encoding p57KIP2 is located at 11p15.5 (ref </plain></SENT>
<SENT sid="2" pm="."><plain>2), a region implicated in both <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>, a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-predisposing syndrome, making it a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-suppressor candidate </plain></SENT>
<SENT sid="3" pm="."><plain>Several types of <z:e sem="disease" ids="C1368871" disease_type="Neoplastic Process" abbrv="">childhood tumours</z:e> including <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumour</z:e>, <z:hpo ids='HP_0006744'>adrenocortical carcinoma</z:hpo> and <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo> exhibit a specific loss of maternal 11p15 alleles, suggesting that <z:mp ids='MP_0003121'>genomic imprinting</z:mp> is involved </plain></SENT>
<SENT sid="4" pm="."><plain>Genetic analysis of the <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> indicated maternal carriers, as well as suggesting a role of <z:mp ids='MP_0003121'>genomic imprinting</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Previously, we and others demonstrated that p57KIP2 is imprinted and that only the maternal allele is expressed in both mice and humans </plain></SENT>
<SENT sid="6" pm="."><plain>Here we describe p57KIP2 mutations in patients with <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Among nine patients we examined, two were heterozygous for different mutations in this gene-a missense mutation in the Cdk inhibitory domain resulting in loss of most of the protein, and a frameshift resulting in disruption of the QT domain </plain></SENT>
<SENT sid="8" pm="."><plain>The missense mutation was transmitted from the patient's carrier mother, indicating that the expressed maternal allele was mutant and that the repressed paternal allele was <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Consequently, little or no active p57KIP2 should exist and this probably causes the <z:hpo ids='HP_0001548'>overgrowth</z:hpo> in this BWS patient </plain></SENT>
</text></document>